IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · IEX Real-Time Price · USD
479.57
+3.22 (0.68%)
Apr 22, 2024, 4:00 PM EDT - Market closed
IDEXX Laboratories Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1994 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3,661 | 3,367 | 3,215 | 2,707 | 2,407 | 2,213 | 1,969 | 1,775 | 1,602 | 1,486 | Upgrade
|
Revenue Growth (YoY) | 8.72% | 4.73% | 18.79% | 12.45% | 8.75% | 12.40% | 10.91% | 10.83% | 7.81% | 7.90% | Upgrade
|
Cost of Revenue | 1,471 | 1,363 | 1,326 | 1,136 | 1,041 | 971.7 | 871.68 | 799.99 | 711.62 | 669.69 | Upgrade
|
Gross Profit | 2,190 | 2,004 | 1,889 | 1,571 | 1,366 | 1,242 | 1,097 | 975.44 | 890.27 | 816.12 | Upgrade
|
Selling, General & Admin | 901.89 | 850.75 | 796.4 | 735.27 | 679.51 | 632.34 | 575.17 | 524.08 | 482.47 | 457.6 | Upgrade
|
Research & Development | 190.95 | 254.82 | 161.01 | 141.25 | 133.19 | 117.86 | 109.18 | 101.12 | 99.68 | 98.26 | Upgrade
|
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.21 | 0 | Upgrade
|
Operating Expenses | 1,093 | 1,106 | 957.4 | 876.52 | 812.7 | 750.21 | 684.35 | 625.2 | 590.36 | 555.86 | Upgrade
|
Operating Income | 1,097 | 898.77 | 932.03 | 694.52 | 552.85 | 491.34 | 413.03 | 350.24 | 299.91 | 260.26 | Upgrade
|
Interest Expense / Income | 41.58 | 39.86 | 29.81 | 33.13 | 31.06 | 34.74 | 37.23 | 32.05 | 29.24 | 15.43 | Upgrade
|
Other Expense / Income | -5.63 | -1.07 | -0.44 | -0.23 | -0.36 | -1.14 | -5.13 | -3.65 | -2.41 | -1.68 | Upgrade
|
Pretax Income | 1,061 | 859.97 | 902.66 | 661.63 | 522.15 | 457.73 | 380.93 | 321.84 | 273.08 | 246.51 | Upgrade
|
Income Tax | 216.13 | 180.88 | 157.81 | 79.85 | 94.43 | 80.7 | 117.79 | 99.79 | 81.01 | 64.6 | Upgrade
|
Net Income | 845.04 | 679.09 | 744.85 | 581.78 | 427.72 | 377.03 | 263.14 | 222.05 | 192.08 | 181.91 | Upgrade
|
Net Income Growth | 24.44% | -8.83% | 28.03% | 36.02% | 13.44% | 43.28% | 18.51% | 15.60% | 5.59% | -3.14% | Upgrade
|
Shares Outstanding (Basic) | 83 | 84 | 85 | 85 | 86 | 87 | 88 | 90 | 93 | 100 | Upgrade
|
Shares Outstanding (Diluted) | 84 | 85 | 87 | 87 | 88 | 88 | 90 | 91 | 94 | 102 | Upgrade
|
Shares Change | -0.74% | -2.28% | -0.17% | -0.94% | -1.05% | -1.22% | -1.45% | -2.95% | -7.74% | -5.99% | Upgrade
|
EPS (Basic) | 10.17 | 8.12 | 8.74 | 6.82 | 4.97 | 4.34 | 3.00 | 2.47 | 2.07 | 1.82 | Upgrade
|
EPS (Diluted) | 10.06 | 8.03 | 8.60 | 6.71 | 4.89 | 4.26 | 2.94 | 2.44 | 2.05 | 1.79 | Upgrade
|
EPS Growth | 25.28% | -6.63% | 28.17% | 37.22% | 14.79% | 44.90% | 20.49% | 19.02% | 14.53% | 2.87% | Upgrade
|
Free Cash Flow | 772.88 | 384.15 | 636 | 540.44 | 304.19 | 284.33 | 298.89 | 274.16 | 138.88 | 175.15 | Upgrade
|
Free Cash Flow Per Share | 9.30 | 4.59 | 7.46 | 6.33 | 3.53 | 3.27 | 3.40 | 3.06 | 1.50 | 1.75 | Upgrade
|
Gross Margin | 59.82% | 59.52% | 58.76% | 58.04% | 56.73% | 56.10% | 55.73% | 54.94% | 55.58% | 54.93% | Upgrade
|
Operating Margin | 29.97% | 26.69% | 28.99% | 25.66% | 22.97% | 22.20% | 20.98% | 19.73% | 18.72% | 17.52% | Upgrade
|
Profit Margin | 23.08% | 20.17% | 23.17% | 21.49% | 17.77% | 17.04% | 13.36% | 12.51% | 11.99% | 12.24% | Upgrade
|
Free Cash Flow Margin | 21.11% | 11.41% | 19.78% | 19.97% | 12.64% | 12.85% | 15.18% | 15.44% | 8.67% | 11.79% | Upgrade
|
Effective Tax Rate | 20.37% | 21.03% | 17.48% | 12.07% | 18.08% | 17.63% | 30.92% | 31.01% | 29.66% | 26.21% | Upgrade
|
EBITDA | 1,218 | 1,012 | 1,037 | 790.75 | 641.21 | 575.65 | 501.3 | 432.1 | 371.28 | 320.83 | Upgrade
|
EBITDA Margin | 33.26% | 30.05% | 32.25% | 29.22% | 26.64% | 26.01% | 25.46% | 24.34% | 23.18% | 21.59% | Upgrade
|
Depreciation & Amortization | 114.91 | 111.9 | 104.6 | 96 | 88.01 | 83.18 | 83.14 | 78.22 | 68.96 | 58.89 | Upgrade
|
EBIT | 1,103 | 899.83 | 932.46 | 694.76 | 553.2 | 492.47 | 418.16 | 353.89 | 302.32 | 261.94 | Upgrade
|
EBIT Margin | 30.12% | 26.72% | 29.00% | 25.67% | 22.98% | 22.25% | 21.24% | 19.93% | 18.87% | 17.63% | Upgrade
|